An immune and epithelial mesenchymal transition-related risk model and immunotherapy strategy for grade ii and iii gliomas

HIGHLIGHTS

• who: IDH and colleagues from the Tongji University, China have published the Article: An immune and epithelial mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas, in the Journal: (JOURNAL)
• what: The authors attempted to construct an immune-related risk model and proposed a feasible strategy for improving the immunotherapy efficacy for gliomas. Next, the authors focused on the correlation between TGFB1/ TGFBR1, PD-L1, CTLA-4, and immune cell infiltration.
• how: The results showed that all 100 genes were significantly associated with prognosis . Through multivariate analysis of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.